scholarly journals Amyloid Beta-Induced Neuronal Death is Bax-Dependent but Caspase-Independent

2000 ◽  
Vol 59 (4) ◽  
pp. 271-279 ◽  
Author(s):  
Lee A. Selznick ◽  
Timothy S. Zheng ◽  
Richard A. Flavell ◽  
Pasko Rakic ◽  
Kevin A. Roth
Keyword(s):  
2016 ◽  
Vol 15 (8) ◽  
pp. 918-926 ◽  
Author(s):  
Hyunjeong Liew ◽  
Yun-Mi Kim ◽  
Hee Soon Choi ◽  
Ah Ram Jang ◽  
David Churchill ◽  
...  

1996 ◽  
Vol 71 ◽  
pp. 176
Author(s):  
Toshiyuki Himi ◽  
Takako Koyaina ◽  
Yasuki Ishizaki ◽  
Sei-itsu Murota

2011 ◽  
Vol 2011 ◽  
pp. 1-13 ◽  
Author(s):  
Mallory Gough ◽  
Catherine Parr-Sturgess ◽  
Edward Parkin

Alzheimer's disease is a neurodegenerative condition characterized by an accumulation of toxic amyloid beta- (A-)peptides in the brain causing progressive neuronal death. A-peptides are produced by aspartyl proteinase-mediated cleavage of the larger amyloid precursor protein (APP). In contrast to this detrimental “amyloidogenic” form of proteolysis, a range of zinc metalloproteinases can process APP via an alternative “nonamyloidogenic” pathway in which the protein is cleaved within its A region thereby precluding the formation of intact A-peptides. In addition, other members of the zinc metalloproteinase family can degrade preformed A-peptides. As such, the zinc metalloproteinases, collectively, are key to downregulating A generation and enhancing its degradation. It is the role of zinc metalloproteinases in this “positive side of proteolysis in Alzheimer's disease” that is discussed in the current paper.


2005 ◽  
Vol 360 (1464) ◽  
pp. 2309-2314 ◽  
Author(s):  
Andrey Y Abramov ◽  
Michael R Duchen

Amyloid beta peptide (Aβ) accumulates in the CNS in Alzheimer's disease. Both the full peptide (1–42) or the 25–35 fragment are toxic to neurons in culture. We have used fluorescence imaging technology to explore the mechanism of neurotoxicity in mixed asytrocyte/neuronal cultures prepared from rat or mouse cortex or hippocampus, and have found that Aβ acts preferentially on astrocytes but causes neuronal death. Aβ causes sporadic transient increases in [Ca 2+ ] c in astrocytes, associated with a calcium dependent increased generation of reactive oxygen species (ROS) and glutathione depletion. This caused a slow dissipation of mitochondrial potential on which abrupt calcium dependent transient depolarizations were superimposed. The mitochondrial depolarization was reversed by mitochondrial substrates glutamate, pyruvate or methyl succinate, and by NADPH oxidase (NOX) inhibitors, suggesting that it reflects oxidative damage to metabolic pathways upstream of mitochondrial complex I. The Aβ induced increase in ROS and the mitochondrial depolarization were absent in cells cultured from transgenic mice lacking the NOX component, gp91 phox . Neuronal death after 24 h of Aβ exposure was dramatically reduced both by NOX inhibitors and in gp91 phox knockout mice. Thus, by raising [Ca 2+ ] c in astrocytes, Aβ activates NOX, generating oxidative stress that is transmitted to neurons, causing neuronal death.


Medicina ◽  
2011 ◽  
Vol 47 (2) ◽  
pp. 15 ◽  
Author(s):  
Paulius Čižas ◽  
Aistė Jekabsonė ◽  
Vilmantė Borutaitė ◽  
Ramunė Morkūnienė

Background and objective. Alzheimer’s disease is a progressive neurodegenerative disease that is biochemically characterized by the accumulation of amyloid beta (Aβ) peptides in the brain. The current hypothesis suggests that Aβ oligomers rather than fibrillar aggregates are the most toxic species of Aβ though the mechanisms of their neurotoxicity are unclear. The authors have previously shown that small Aβ1–42 oligomers at around 1 μM concentration caused rapid (in 24 h) neuronal death in cerebellar granule cell (CGC) cultures. In this study, we aimed to investigate whether protracted (up to 7 days) incubation of CGC cultures with lower submicromolar concentration of various aggregates of Aβ1–42 had an effect on viability of neurons. In order to get some insight into the mechanism of Aβ-induced cell death, we also sought to determine whether extracellular Ca2+ and process of endocytosis contributed to Aβ oligomer-induced neurotoxicity and whether pharmacological interventions into these processes would prevent Aβ oligomer-induced cell death. Material and Methods. Primary cultures of CGC were treated with various aggregate forms of Aβ1–42. Cell viability was assessed by fluorescent microscopy using propidium iodide and Hoechst 33342 staining. Results. Exposure of neurons to 500 nM Aβ1–42 oligomers for 72–168 h caused extensive neuronal necrosis. Lower concentrations (100–250 nM) were not toxic to cells during 7 days of incubation. Aβ1–42 monomers and fibrils had no effect on neuronal viability even after 7 days of incubation. Treatment of neurons with EGTA, steroid hormone 17β-estradiol, and methyl-β-cyclodextrin significantly reduced Aβ1-42 oligomers-induced neuronal death. Conclusions. The results show that submicromolar concentrations of Aβ1-42 oligomers were highly toxic to neurons during protracted incubation inducing neuronal necrosis that can be prevented by chelating extracellular Ca2+ with EGTA, inhibiting endocytosis with methyl-β-cyclodextrin, or by estradiol, which may protect against mitochondrial permeability transition pore opening.


2009 ◽  
Vol 283 (1-2) ◽  
pp. 280-281
Author(s):  
E. Ferreiro ◽  
R. Costa ◽  
R. Resende ◽  
S. Marques ◽  
S. Cardoso ◽  
...  

2002 ◽  
Vol 38 ◽  
pp. 37-49 ◽  
Author(s):  
Janelle Nunan ◽  
David H Small

The proteolytic processing of the amyloid-beta protein precursor plays a key role in the development of Alzheimer's disease. Cleavage of the amyloid-beta protein precursor may occur via two pathways, both of which involve the action of proteases called secretases. One pathway, involving beta- and gamma-secretase, liberates amyloid-beta protein, a protein associated with the neurodegeneration seen in Alzheimer's disease. The alternative pathway, involving alpha-secretase, precludes amyloid-beta protein formation. In this review, we describe the progress that has been made in identifying the secretases and their potential as therapeutic targets in the treatment or prevention of Alzheimer's disease.


Sign in / Sign up

Export Citation Format

Share Document